Two leading specialists in eosinophilic esophagitis (EoE) explore the increasing disease burden of this underrecognized cause of esophageal dysfunction that affects all age groups worldwide. A type-2 inflammatory condition, EoE is frequently characterized by allergic comorbidity but can also be misdiagnosed as the more common condition of gastroesophageal reflux disease. New and emerging treatments promise to improve outcomes for people with EoE. Drs. Mirna Chehade and Ikuo Hirano share best practices, as well as their own insights and clinical pearls based on their research and clinical practice with children and adults with EoE. This can lead to more expedient diagnosis, better adherence to treatment, and reduced disease burden. This interactive, case-based activity is designed for practicing clinicians. The faculty include lessons learned, quality-of-life considerations, and the near-term outlook for management of people with EoE.  

Presenting Faculty

• 

  Mirna Chehade, MD, MPH

  Professor of Pediatrics and Medicine
  Founding Director, Mount Sinai Center for Eosinophilic Disorders
  Icahn School of Medicine at Mount Sinai
  New York, New York

• 

  Ikuo Hirano, MD

  Professor of Medicine
  Division of Gastroenterology and Hepatology
  Northwestern University Feinberg School of Medicine
  Chicago, Illinois